Sanara Medtech Inc
NASDAQ:SMTI
Sanara Medtech Inc
Revenue
Sanara Medtech Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sanara Medtech Inc
NASDAQ:SMTI
|
Revenue
$65m
|
CAGR 3-Years
61%
|
CAGR 5-Years
62%
|
CAGR 10-Years
44%
|
|
Haemonetics Corp
NYSE:HAE
|
Revenue
$1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Cooper Companies Inc
NYSE:COO
|
Revenue
$3.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Revenue
$4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Revenue
$3.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
Sanara Medtech Inc
Revenue Breakdown
Breakdown by Geography
Sanara Medtech Inc
Breakdown by Segments
Sanara Medtech Inc
Total Revenue:
65m
USD
|
Soft Tissue Repair Products:
54.8m
USD
|
Bone Fusion Products:
10m
USD
|
Royalty:
201k
USD
|
See Also
What is Sanara Medtech Inc's Revenue?
Revenue
65m
USD
Based on the financial report for Dec 31, 2023, Sanara Medtech Inc's Revenue amounts to 65m USD.
What is Sanara Medtech Inc's Revenue growth rate?
Revenue CAGR 10Y
44%
Over the last year, the Revenue growth was 42%. The average annual Revenue growth rates for Sanara Medtech Inc have been 61% over the past three years , 62% over the past five years , and 44% over the past ten years .